227 related articles for article (PubMed ID: 11046117)
1. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
Perchenet L; Clément-Chomienne O
J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
[TBL] [Abstract][Full Text] [Related]
2. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
[TBL] [Abstract][Full Text] [Related]
3. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
4. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
Choe H; Lee YK; Lee YT; Choe H; Ko SH; Joo CU; Kim MH; Kim GS; Eun JS; Kim JH; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825
[TBL] [Abstract][Full Text] [Related]
5. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
6. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
7. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
9. Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5.
Zhang X; Anderson JW; Fedida D
J Pharmacol Exp Ther; 1997 Jun; 281(3):1247-56. PubMed ID: 9190860
[TBL] [Abstract][Full Text] [Related]
10. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
11. Properties of the delayed rectifier potassium current in porcine sino-atrial node cells.
Ono K; Shibata S; Iijima T
J Physiol; 2000 Apr; 524 Pt 1():51-62. PubMed ID: 10786611
[TBL] [Abstract][Full Text] [Related]
12. Anomalous effects of external TEA on permeation and gating of the A-type potassium current in H. aspersa neuronal somata.
Denton JS; Leiter JC
J Membr Biol; 2002 Nov; 190(1):17-28. PubMed ID: 12422269
[TBL] [Abstract][Full Text] [Related]
13. Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channel.
Rampe D; Wang Z; Fermini B; Wible B; Dage RC; Nattel S
J Pharmacol Exp Ther; 1995 Jul; 274(1):444-9. PubMed ID: 7616429
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human cardiac Kv1.5 inhibition by the novel atrial-selective antiarrhythmic compound AVE1231.
Ehrlich JR; Ocholla H; Ziemek D; Rütten H; Hohnloser SH; Gögelein H
J Cardiovasc Pharmacol; 2008 Apr; 51(4):380-7. PubMed ID: 18427281
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
Malayev AA; Nelson DJ; Philipson LH
Mol Pharmacol; 1995 Jan; 47(1):198-205. PubMed ID: 7838129
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
Aczél S; Kurka B; Hering S
Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
[TBL] [Abstract][Full Text] [Related]
17. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels.
Franqueza L; Valenzuela C; Delpón E; Longobardo M; Caballero R; Tamargo J
Br J Pharmacol; 1998 Nov; 125(5):969-78. PubMed ID: 9846634
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.
Valenzuela C; Delpón E; Tamkun MM; Tamargo J; Snyders DJ
Biophys J; 1995 Aug; 69(2):418-27. PubMed ID: 8527655
[TBL] [Abstract][Full Text] [Related]
19. HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers.
Chouabe C; Drici MD; Romey G; Barhanin J; Lazdunski M
Mol Pharmacol; 1998 Oct; 54(4):695-703. PubMed ID: 9765513
[TBL] [Abstract][Full Text] [Related]
20. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
